A 15-year-old patient diagnosed with Dravet syndrome (a severe myoclonic epilepsy of infants) and cognitive impairment is under topiramate, valproate, and levetiracetam treatment. Because of the presentation of several epileptic… Click to show full abstract
A 15-year-old patient diagnosed with Dravet syndrome (a severe myoclonic epilepsy of infants) and cognitive impairment is under topiramate, valproate, and levetiracetam treatment. Because of the presentation of several epileptic crises in recent weeks, potassium bromide was added to his medication regimen. The number of crises decreased, …
               
Click one of the above tabs to view related content.